GlobeNewswire

City Therapeutics to Present at Upcoming November Investor Conferences
03/11/2026
CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics, today announced [...]
Geron Corporation to Participate in the Stifel 2026 Healthcare Conference
03/11/2026
FOSTER CITY, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today [...]
Humacyte Innovative Research in Coronary Bypass and Vascular Regeneration to be Highlighted at American Heart Association Scientific Sessions 2026
03/11/2026
– Founder & CEO Laura Niklason, M.D., Ph.D., to deliver invited talk on engineering the microenvironment to accelerate vascular regeneration. – Two additional presentations to cover first-in-human Phase 2a study [...]
Cabaletta Bio to Participate in Upcoming Investor Conferences
03/11/2026
PHILADELPHIA, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically [...]
Avalyn to Present at Upcoming Investor Conferences
03/11/2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
Bolt Biotherapeutics to Participate in Upcoming Conferences
03/11/2026
REDWOOD CITY, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT) (“Bolt” or the “Company”), a clinical-stage biotechnology company pioneering a new generation of half-life-extended [...]
4DMT to Participate in Upcoming Investor Conferences
03/11/2026
EMERYVILLE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
03/11/2026
ORLANDO, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, [...]
Santé des enfants Canada publie Le meilleur départ, une feuille de route nationale pour transformer les systèmes de santé des enfants et des jeunes
03/11/2026
Le meilleur départ présente une vision à l’intention des gouvernements fédéral, provinciaux et territoriaux pour améliorer la qualité et l’équité des soins de santé aux 8,6 millions d’enfants au Canada OTTAWA, Ontario, [...]
Children’s Healthcare Canada releases Start Strong, a National Playbook to Transform Child and Youth Health Systems
03/11/2026
Start Strong sets out a vision for federal, provincial, and territorial governments to deliver better, more equitable healthcare to Canada's 8.6 million children OTTAWA, Ontario, Nov. 03, 2026 (GLOBE NEWSWIRE) -- [...]
Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting
03/11/2026
Two Invited Presentations Showcase Clinical Progress in Solid Tumors and Allogene's Broader Vision in Oncology and Autoimmune Disease Preclinical Poster Features Next-Generation DLL3/CD70 Dual CAR T Product Candidate [...]
Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx
03/11/2026
Potential to pay as little as $0 per fill for VOQUEZNA, plus free home delivery and prior authorization support, makes it simpler for GERD patients to get the medicine their doctor prescribed A Media Snippet [...]
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
03/11/2026
MONTREAL and CHARLOTTE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test
03/11/2026
Collaboration closes the loop between AI drug design and human biology: Chemveda designs and makes the molecules, VivoSim’s NAMkind™ 3D human liver and intestine models show which ones are safe to advance, in weeks [...]
FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients
03/11/2026
DENVER, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure [...]
Celcuity To Participate in Upcoming Investor Conferences
03/11/2026
MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, [...]
Sofwave Medical Reports Third Quarter 2026 Financial Results and Business Highlights
03/11/2026
Third quarter revenue of $28.5M, +35% year-over-year growth; IFRS gross margin of 76.6% Third quarter usage fee revenue of $13.3M, +60% year-over-year growth First nine months revenue of $82.9M, +41% year-over-year [...]
Vivos Inc. Announces Expansion of IsoPet® Animal Cancer Division with Four New Veterinary Clinics Across the United States
03/11/2026
Kennewick, WA, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, is pleased to announce [...]
OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30
03/11/2026
Expansion option exercised within weeks as customer increases data volume to support its derivative data offering MINNEAPOLIS, Nov. 03, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “ [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum